These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 16740776

  • 41. p38alpha MAP kinase-deficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons.
    Guo YL, Ye J, Huang F.
    Dev Dyn; 2007 Dec; 236(12):3383-92. PubMed ID: 17994546
    [Abstract] [Full Text] [Related]

  • 42. Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
    Beedie SL, Peer CJ, Pisle S, Gardner ER, Mahony C, Barnett S, Ambrozak A, Gütschow M, Chau CH, Vargesson N, Figg WD.
    Mol Cancer Ther; 2015 Oct; 14(10):2228-37. PubMed ID: 26269604
    [Abstract] [Full Text] [Related]

  • 43. Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors.
    Zaman GJ, van der Lee MM, Kok JJ, Nelissen RL, Loomans EE.
    Assay Drug Dev Technol; 2006 Aug; 4(4):411-20. PubMed ID: 16945014
    [Abstract] [Full Text] [Related]

  • 44. Thalidomide analogues as anticancer drugs.
    Aragon-Ching JB, Li H, Gardner ER, Figg WD.
    Recent Pat Anticancer Drug Discov; 2007 Jun; 2(2):167-74. PubMed ID: 17975653
    [Abstract] [Full Text] [Related]

  • 45. Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cánovas B, Igea A, Sartori AA, Gomis RR, Paull TT, Isoda M, Pérez-Montoyo H, Serra V, González-Suárez E, Stracker TH, Nebreda AR.
    Cancer Cell; 2018 Jun 11; 33(6):1094-1110.e8. PubMed ID: 29805078
    [Abstract] [Full Text] [Related]

  • 46. p38alpha MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum.
    Zuluaga S, Gutiérrez-Uzquiza A, Bragado P, Alvarez-Barrientos A, Benito M, Nebreda AR, Porras A.
    FEBS Lett; 2007 Aug 07; 581(20):3819-25. PubMed ID: 17658519
    [Abstract] [Full Text] [Related]

  • 47. [Search for new anti-angiogenic agents with structural analogy with thalidomide].
    Vidal M, Gasse C, Garbay C, Galons H.
    Ann Pharm Fr; 2005 Jan 07; 63(1):85-9. PubMed ID: 15803105
    [Abstract] [Full Text] [Related]

  • 48. Development of a p38α-selective radioactive probe for qualitative diagnosis of cancer using SPECT.
    Hirata M, Yao T, Fujimura S, Kanai Y, Yoshimoto M, Sato T, Ohmomo Y, Temma T.
    Ann Nucl Med; 2019 May 07; 33(5):333-343. PubMed ID: 30953245
    [Abstract] [Full Text] [Related]

  • 49. A p38α-selective chemosensor for use in unfractionated cell lysates.
    Stains CI, Luković E, Imperiali B.
    ACS Chem Biol; 2011 Jan 21; 6(1):101-5. PubMed ID: 20845953
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Potential adverse effects associated with inhibition of p38alpha/beta MAP kinases.
    Dambach DM.
    Curr Top Med Chem; 2005 Jan 21; 5(10):929-39. PubMed ID: 16178738
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.
    Ruddy JM, Majumdar SK.
    J Biomed Biotechnol; 2002 Jan 21; 2(1):7-13. PubMed ID: 12488594
    [Abstract] [Full Text] [Related]

  • 57. DMSO exhibits similar cytotoxicity effects to thalidomide in mouse breast cancer cells.
    Oz ES, Aydemir E, Fışkın K.
    Oncol Lett; 2012 Apr 01; 3(4):927-929. PubMed ID: 22741020
    [Abstract] [Full Text] [Related]

  • 58. Diversity and versatility of p38 kinase signalling in health and disease.
    Canovas B, Nebreda AR.
    Nat Rev Mol Cell Biol; 2021 May 01; 22(5):346-366. PubMed ID: 33504982
    [Abstract] [Full Text] [Related]

  • 59. In Situ Target Engagement Studies in Adherent Cells.
    Axelsson H, Almqvist H, Otrocka M, Vallin M, Lundqvist S, Hansson P, Karlsson U, Lundbäck T, Seashore-Ludlow B.
    ACS Chem Biol; 2018 Apr 20; 13(4):942-950. PubMed ID: 29433316
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.